[A novel strategy of immno-modulation in sepsis].
Lin
Hong-Yuan
HY
304th Hospital of PLA, Beijing 100037, China.
Sheng
Zhi-Rong
ZR
D000276:Adjuvants, Immunologic / Q000627:therapeutic use; D017209:Apoptosis / Q000276:immunology; D006023:Glycoproteins / Q000627:therapeutic use; D006801:Humans; D008214:Lymphocytes / Q000378:metabolism; D018805:Sepsis / Q000188:drug therapy* / Q000276:immunology* / Q000378:metabolism; D000077596:Thymalfasin; D013947:Thymosin / Q000031:analogs & derivatives* / Q000627:therapeutic use; D014361:Trypsin Inhibitors / Q000627:therapeutic use
D000276:Adjuvants, Immunologic; D006023:Glycoproteins; D014361:Trypsin Inhibitors; D013947:Thymosin; C028665:urinastatin; D000077596:Thymalfasin